HNGE
Hinge Health, Inc.NYSEHealthcare$38.98+1.27%ClosedMarket Cap: $3.07B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
8.23
P/S
5.25
EV/EBITDA
-5.48
DCF Value
$-147.37
FCF Yield
5.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.6%
Operating Margin
-92.4%
Net Margin
-89.9%
ROE
-132.2%
ROA
-70.9%
ROIC
-140.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $170.7M | 84.4% | $27.3M | $32.1M | $0.37 | — |
| FY 2025 | $587.9M | 79.6% | $-546.4M | $-528.3M | $-5.19 | — |
| Q3 2025 | $154.2M | 81.8% | $-6.1M | $-1.8M | $-0.02 | — |
| Q2 2025 | $139.1M | 70.3% | $-579.3M | $-575.7M | $-7.38 | — |
| Q1 2025 | $123.8M | 80.9% | $14.8M | $17.1M | $1.55 | — |
| Q4 2024 | $117.3M | 81.9% | $21.3M | $27.1M | $0.35 | — |
| FY 2024 | $390.4M | 77.0% | $-24.4M | $-11.9M | $-0.15 | — |
| Q3 2024 | $100.6M | 78.8% | $-3.9M | $341.0K | $0.00 | — |
| Q2 2024 | $89.8M | 74.2% | $-9.9M | $-12.9M | $-0.14 | — |
| Q1 2024 | $82.7M | 70.1% | $-30.4M | $-26.5M | $-0.34 | — |
| Q4 2023 | $81.5M | 71.7% | $-30.5M | $-24.1M | $-0.31 | — |
| FY 2023 | $292.7M | 66.3% | $-130.5M | $-108.1M | $-1.39 | — |